Drug intelligence / Profile preview

Cortin

Development stage
Unknown
Lead developer
Yash Pharma Laboratories
Modality
Small Molecules
Administration
Topical
01

Overview

Cortin is a topical combination medication developed and marketed by Yash Pharma Laboratories, primarily used in the field of dermatology. It is formulated as a spray containing two active ingredients: hydrocortisone, a mild corticosteroid, and oxytetracycline, a broad-spectrum tetracycline antibiotic. This combination is specifically indicated for the treatment of inflammatory skin conditions, such as eczema, contact dermatitis, and seborrheic dermatitis, particularly when a secondary bacterial infection is present or likely to occur. Hydrocortisone functions as a glucocorticoid receptor agonist, exerting anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating gene expression to reduce the production of inflammatory mediators. Oxytetracycline provides antibacterial action by binding to the 30S ribosomal subunit of susceptible bacteria, thereby inhibiting protein synthesis and preventing bacterial growth. The spray formulation allows for easy application to affected skin areas, providing both symptomatic relief from inflammation and targeted antimicrobial therapy.

Brand names
CortinCortin Spray
Other names
hydrocortisone + oxytetracycline
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Cortin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call